Abstract: . . .  19.5 19.3 0.975 Fibrate, % 2.4 1.2 0.608 Sulfonylurea, % 7.3 3.6 0.366 Biguanide, % 9.8 2.4 0.073 AGI, % 0.0 0.0 Insulin, % 2.4 0.0 0.153 Insulin sensitizer, % 2.4 6.0 0.381 ABI = ankle-brachial index; AGI = a-glucosidase inhibitor; BMI = body mass index; baPWV = brachial-ankle pulse wave velocity; HDL = high- density lipoprotein; LDL = low-density lipoprotein; SBP = systolic blood pressure. Page 6 Arteriosclerosis and atherosclerosis in stable patients J Chin Med Assoc January 2006 Vol 69 No 1 19 New clinical decisions Based on the readily available reports of baPWV and ABI at the clinic, the cardiologist judged to adjust the medications in 56 patients (45.2%). In brief, new classes of antihypertensive drugs were added in 33.9%, original . . .
. . .  Hypertens 2002;15:4538. 23. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001;344:160821. 24. Kubo T, Miyata M, Minagoe S, Setoyama S, Maruyama I, Tei C. A simple oscillometric technique for determining new indices of arterial distensibility. Hypertens Res 2002;25:3518. 25. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, Creager MA, et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003;163:88492. 26. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:14553. 27. Burns P, Gough S, Bradbury AW. Management of peripheral arterial disease in primary care. BMJ 2003;326:5848.  . . .
. . .  19.5 19.3 0.975 Fibrate, % 2.4 1.2 0.608 Sulfonylurea, % 7.3 3.6 0.366 Biguanide, % 9.8 2.4 0.073 AGI, % 0.0 0.0 Insulin, % 2.4 0.0 0.153 Insulin sensitizer, % 2.4 6.0 0.381 ABI = ankle-brachial index; AGI = a-glucosidase inhibitor; BMI = body mass index; baPWV = brachial-ankle pulse wave velocity; HDL = high- density lipoprotein; LDL = low-density lipoprotein; SBP = systolic blood pressure. Page 6 Arteriosclerosis and atherosclerosis in stable patients J Chin Med Assoc January 2006 Vol 69 No 1 19 New clinical decisions Based on the readily available reports of baPWV and ABI at the clinic, the cardiologist judged to adjust the medications in 56 patients (45.2%). In brief, new classes of antihypertensive drugs were added in 33.9%, original . . .
--3000,3,500,3159,35266